Stichting Martini Ziekenhuis

At Stichting Martini Ziekenhuis in Groningen, the Cardio Research Noord team is active in cardiovascular diseases and related risk reduction studies. The research focuses on improving prevention and treatment for conditions such as atherosclerotic cardiovascular disease, atrial fibrillation, peripheral arterial disease, and heart failure, with many trials aimed at lowering major cardiovascular events and refining long-term care.

• Testing new therapies to reduce the risk of heart attack, stroke, and other serious vascular events
• Studying rhythm control and stroke prevention in atrial fibrillation
• Evaluating treatments for lipid disorders and elevated lipoprotein(a)
• Assessing better approaches for patients with peripheral artery disease and broader cardiovascular risk

These studies combine prevention, symptom control, and outcome improvement, reflecting a strong emphasis on practical advances in everyday cardiology.

The site is also a busy center for oncology and hematology research, covering cancers such as non-small cell lung cancer, breast cancer, colorectal cancer, prostate cancer, and blood cancers including chronic lymphocytic leukemia, lymphoma, and multiple myeloma. Many trials aim to improve survival, delay progression, and support more personalized treatment choices.

• Exploring new cancer treatments and combinations for advanced solid tumors
• Improving outcomes in lung cancer, breast cancer, and colorectal cancer
• Studying targeted and immune-based approaches in lymphoma and leukemia
• Testing biomarker-guided strategies to match patients with more effective therapies

Research at Stichting Martini Ziekenhuis includes both treatment effectiveness and ways to tailor care more closely to the biology of each disease.

Clinical trials in respiratory diseases and intensive care examine conditions such as COPD, asthma, pulmonary sarcoidosis, and acute respiratory tract infection. The research also includes studies in critically ill patients, aiming to improve recovery, reduce complications, and support better hospital care.

• Evaluating new treatments for COPD and asthma
• Comparing therapies for pulmonary sarcoidosis to improve disease control
• Testing interventions for hospitalized patients with acute respiratory infection
• Studying care strategies for adults admitted to the intensive care unit

These projects focus on both symptom relief and better clinical outcomes, especially for patients with serious breathing problems or critical illness.

Another important area at the site is gastrointestinal and surgical research, especially in rectal cancer, esophageal cancer, and early-stage colorectal disease. Trials often look at organ-preserving treatment, improved cancer control, and better surgical visualization or recovery.

• Testing organ-preserving strategies for early rectal cancer
• Evaluating adjuvant approaches to reduce recurrence after surgery for rectal cancer
• Improving surgical guidance and anatomical visualization during abdominal procedures
• Studying new approaches for esophageal cancer and related digestive system cancers

This work reflects a strong interest in balancing effective cancer treatment with quality of life and function after therapy.

The research portfolio also includes metabolic, endocrine, and kidney disease studies. Key conditions include obesity, gestational diabetes, hyperthyroidism, and chronic kidney disease, with trials designed to improve disease management and reduce long-term complications.

• Investigating better care for gestational diabetes during and after pregnancy
• Studying treatments for chronic kidney disease and related cardiovascular risk
• Comparing options for hyperthyroidism to support safer thyroid control
• Evaluating therapies aimed at lowering weight-related and metabolic risk

These studies show an emphasis on prevention, chronic disease management, and protecting organ function over time.

Research at Stichting Martini Ziekenhuis also spans immune system diseases, rheumatology, and infectious diseases. Trials address conditions such as primary progressive multiple sclerosis, ACPA positive arthralgia, rheumatoid arthritis risk, Staphylococcus aureus bacteremia, and other serious infections, with the goal of improving early detection and treatment response.

• Testing new approaches for multiple sclerosis and inflammatory disease
• Studying markers that may predict progression to arthritis
• Evaluating treatments for serious bloodstream and respiratory infections
• Exploring immune-related strategies to improve diagnosis and care

This area combines prevention, biomarker research, and treatment evaluation across both chronic inflammatory disease and acute infection.

The site contributes to women’s health research through studies in contraception, pregnancy-related conditions, and vulvar disease. These trials aim to improve safety, effectiveness, and recurrence prevention in areas that directly affect reproductive and gynecologic health.

• Assessing new contraceptive options for women
• Improving care for gestational diabetes mellitus
• Testing ways to prevent recurrence of vulvar high-grade squamous intraepithelial lesion
• Supporting broader reproductive and urinary health research

The focus is on practical solutions that can improve everyday care for women across different stages of life.

A distinct part of the portfolio involves diagnostic techniques, medical imaging, and health care quality research. These studies look at better ways to identify disease, predict outcomes, and support more precise treatment decisions across several specialties.

• Developing imaging tools to improve detection and monitoring of disease
• Studying diagnostic markers for cancer, inflammatory disease, and cardiovascular risk
• Evaluating methods that may improve the quality and efficiency of care
• Exploring tools that help clinicians choose the most appropriate treatment path

This research supports a more accurate and patient-centered approach to care, linking diagnosis with treatment selection and follow-up.